Praesidia Biotherapeutics
Arlington, US · Founded 2021 · Delaware corporation · 5 employees on LinkedIn
Founders & leadership
SC
Sohang ChatterjeeExecutive
PM
Pradip MajumderExecutive
JR
John RippleNamed on SEC filing
Board
ST
Shawn TitcombBoard director
ML
Martin LehrBoard director
Reported raises · per SEC filings
Form D private placements$11.4M disclosed across 2 rounds · 2021–2024
▶$7.4MraisedJul 2024 · 52 investors · BiotechnologyRule 506(b)
▶$7.4MraisedJul 2024 · 52 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Sohang ChatterjeeExecutive Officer, Director
- Shawn TitcombDirector
- Pradip MajumderExecutive Officer
- Martin LehrDirector
- Offering amount
- $15M
- Amount sold
- $7.4M
- Sales commissions
- $310K
- Placement agents
- Wilmington Capital Securities, LLC
- First sale
- Mar 2024
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
▶$4MraisedAug 2022 · 55 investors · BiotechnologyRule 506(b)
▶$4MraisedAug 2022 · 55 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Martin LehrDirector
- John RippleDirector
- Sohang ChatterjeeExecutive Officer, Director
- Shawn TitcombDirector
- Pradip MajumderExecutive Officer
- Offering amount
- $10M
- Amount sold
- $4M
- Sales commissions
- $700K
- Placement agents
- Wilmington Capital Securities, LLC
- First sale
- Jul 2021
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- How much funding has Praesidia Biotherapeutics raised?
- Praesidia Biotherapeutics has disclosed $11.4M raised across 2 rounds.
- Where is Praesidia Biotherapeutics headquartered?
- Praesidia Biotherapeutics is headquartered in Arlington, US.